Expert Biotechnology Market Analysts Consultants

AI meets biotech — straight from Zug, Switzerland Get the latest AI news, learn must-know AI tools, and keep up with Biotech news in just 5 minutes a week. Join our readers growing their careers with the AIxBiotech newsletter. Founded by executives who have led global biotech and tech teams, AIxBiotech is on a mission to make AI practical for themodern biotech office. In just a few months, we’ve attracted a fast-growing audience of biotech professionals and innovation leaders — from early-stage founders to Fortune 500 executives. Our readers span Europe and North America, with a strong base in the U.S. and Switzerland. We’re building organically, one engaged reader at a time — with the ambition to reach 500K professionals within our first year.

Skilled, highly knowledgeable, and analytical professional with over fourteen years experience in the healthcare sector. Primary expertise in providing strategic insights and actionable information to life science companies. Proficient in molecular diagnostics, point of care diagnostics, genomics, immunoassays, oncology diagnostics, cardiology diagnostics, infectious disease diagnostics and personalized medicine. Strong ability in capturing customer insights, performing technical analysis, sizing niche segments, financial modeling, evaluating market dynamics, identify/evaluate new product potential, and presenting high impact, tactical recommendations. Specialties: Extensive knowledge in the genomics, in-vitro diagnostics space. Demonstrated success in managing teams and clients, assessing business models identifying market opportunities/risks and developing strategies to optimize market penetration, competitive advantage and profit.

I'm a digital marketer who lives at the intersection of creativity and strategy. For 6+ years, I’ve been crafting campaigns that don’t just grab attention—they deliver results. From SEO that ranks to social media that connects, and ads that convert, I turn ideas into impactful outcomes. I believe in the power of data to tell stories, using tools like Zoho Analytics to uncover insights and optimize strategies that drive measurable growth. What fuels me? Turning complex challenges into seamless marketing solutions. Whether it’s designing integrated campaigns, building brands online, or diving deep into analytics, I thrive on making marketing smarter, faster, and more effective. What I Bring to the Table: Growth-focused strategies * Storytelling that sells Websites that work Insights from data Let’s transform your marketing into a growth engine—one campaign at a time.

Authentic technology recruitment leader with expertise in executive talent acquisition and building high performance recruitment teams, primarily within the tech/digital/creative disciplines.

Food Research Lab is a Global Advanced Contract Research, Development and Pilot Manufacturing Organization (CDMO) that provides solutions to the Food, Beverage, Nutraceuticals, cosmeceutical, Pet food & Agriculture sectors worldwide.

Dr. Akshaya Srikanth Bhagavathula is an Associate Professor of Epidemiology at North Dakota State University, internationally recognized for his pioneering work at the intersection of digital epidemiology, pharmacovigilance, and artificial intelligence. His research harnesses advanced statistical modeling and AI to track and predict health behaviors, medication safety, and disease patterns in real time—bridging traditional epidemiology with next-generation digital health analytics. Dr. Bhagavathula has published more than 250 peer-reviewed articles in leading journals, including Annals of Epidemiology, JAMA Network Open, and Lancet Digital Health. His work has been widely cited and featured in major media outlets such as The New York Times, where he discussed the real-world safety of GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy, Mounjaro). Recognized among the Stanford–Elsevier Top 2% of Scientists (2019–2024) and elected as a Fellow of the American College of Epidemiology, Dr. Bhagavathula is known for translating complex data into actionable insights that shape public health policy and clinical practice. His ongoing projects include NIH- and NSF-aligned initiatives on AI-powered overdose forecasting, digital twins for public health, and real-world drug safety surveillance using explainable machine learning. With a decade of experience spanning more than two dozen countries and collaborations with organizations such as WHO, USAID, and UNICEF, Dr. Bhagavathula brings a global, data-driven, and human-centered approach to solving modern health crises.

Influencer | Featured on Times of India | 4x World Record Holder | 10x Microsoft & Azure Certified Expert | ITIL® 4 Specialist Certified | 44x IBM & Design Thinking Certified | SNOW | NOC/IMS/CIS Specialist | Digital & Social Media Marketer | Brand Promoter & Lead Generator

Ganesh Ariyur is a global enterprise technology executive and a Top 100 Digital Adoption Leader for 2025. He is known for delivering more than $500M in measurable enterprise value through large-scale digital transformation, enterprise systems modernization, cloud strategy, artificial intelligence adoption, data governance, & enterprise architecture leadership. His work spans more than 90 countries across Fortune 500 organizations, private-equity owned companies, and highly regulated industries. Ganesh serves as the Global Head of Enterprise Technology Strategy and Transformation at Gainwell Technologies, a $3B healthcare technology organization. He directs modernization programs across SAP S/4HANA, Oracle Cloud ERP, PeopleSoft, cloud platforms on AWS and Azure, enterprise applications, reporting and analytics, generative AI, intelligent automation, enterprise architecture, IT governance, and cybersecurity, aligned with operating models. His programs have delivered multi-million-dollar cost savings. He has directed enterprise portfolios valued at more than $1B. He has unified 450-plus legacy systems, led technology programs supporting more than $30B in M&A value, and guided organizations through complex TSA exits and carve-outs. Ganesh brings deep expertise in artificial intelligence-enabled operating models, multi-ERP modernization including SAP S/4 HANA, Oracle Cloud, & Workday, cloud strategy and FinOps, enterprise architecture, data, infrastructure, cybersecurity improvement, data quality & analytics modernization, robotic process automation & intelligent automation, shared services/global business services, organizational design, and long-term value creation. His people-process-technology approach led to his being named a Global Top 100 Digital Adoption Leader. He is a Certified AI Business Transformation Practitioner & a Certified Technology Innovation Practitioner. He is also a member of the Forbes Technology Council. He was publicly recognized for global transformation leadership when he was featured on billboards across Germany during a major enterprise program at Bayer. Ganesh is known for partnering with boards, CEOs, CFOs, & private equity operating teams. He aligns technology strategy with growth objectives, cost discipline, compliance needs, & long-term enterprise value. Based in Atlanta, he is regarded as a CIO leader who turns complexity into clarity and who consistently converts technology investment into measurable business outcomes.

Dr. James Utley is a pioneering scientist at the forefront of cellular therapy, AI, and data science. A Johns Hopkins-educated Immunohematology expert and Certified Advanced Biotherapies Professional (CABP), he also holds advanced certifications in data science and machine learning. While serving as Technical Director at a major healthcare organization, Dr. Utley oversaw more than 150,000 successful cellular transfusions and spearheaded advancements that significantly improved patient outcomes. This experience included leading initiatives for the Department of Defense, where he revolutionized cellular transfusion practices. His innovative approach is further exemplified by his FDA-approved work and numerous publications in leading scientific journals. Dr. Utley is also known for his bold, hands-on approach to research, embodying the spirit of a "biohacker" by pushing the boundaries of CRISPR and genetic engineering through self-experimentation. This unique blend of rigorous scientific training and unconventional methods has earned him the moniker "the pirate" within the biohacker community.

Founder & CEO of Genbounty - AI safety & compliance testing. Genbounty is a an AI safety testing hub and provider of EU AI Act compliance and certification. About me AppSec SME, AI Engineer, Developer | BSc, MBA, PRINCE2, CompTIA+, CISSP

Drumil Joshi is a nationally recognized leader in AI-driven predictive analytics for renewable energy systems. With a Master of Science in Data Science from Indiana University Bloomington and a portfolio of 12 international research papers, 6 patents, and a published book, Drumil combines academic excellence with real-world operational impact. As the sole Monitoring & Diagnostics Analyst at Southern Power, he manages a $450M portfolio of solar, wind, and battery energy storage assets. He specializes in building end-to-end machine learning pipelines, real-time anomaly detection platforms, and operational stability indices that have enhanced renewable energy reliability and reduced manual analysis time by over 25 hours per week. Drumil’s innovative work—featuring cutting-edge tools like Azure Databricks, SHAP interpretability, and Dash visual analytics—has been nationally recognized by media outlets such as Hindustan Times, DNA India, TechBullion, and Silicon India. His mission is to democratize AI innovation for energy and industrial systems by providing tactical, scalable solutions that companies can implement without needing large teams. With a strong foundation in machine learning, energy analytics, automation, and sustainable AI systems, Drumil offers a unique blend of technical depth, entrepreneurial spirit, and thought leadership that continues to shape the future of smart energy management.

Rebecca Aba Gaisie is a recognized expert in sustainability and energy management, currently conducting high-impact research at Eastern Illinois University. She is the first-place recipient of the 2025 Award for Excellence in Student Research for her work on biodegradable packaging solutions for the beverage industry in developing markets. Her expertise spans Carbon Capture Deployment (CCS) in U.S. oil fields, the circular economy, and the strategic implementation of UN Sustainable Development Goals (SDGs). Rebecca’s work bridges the gap between technical energy transition strategies and practical business sustainability.

David Selakovic is the CEO and President of Vegalab SA, a Swiss biotech advancing natural solutions for global food systems. Under his leadership, Vegalab develops high-performance biologicals and specialty inputs that help growers boost yield and quality while shrinking chemical footprints and protecting pollinators. The company’s platforms—micronization, nano-encapsulation, and in-vivo cultivation of beneficial microorganisms—are engineered to match the efficacy and usability of synthetics, with sustainability built in from the start. Headquartered in Switzerland with a growing international footprint, Vegalab supports farmers, distributors, and innovators across regions with rapid product development and field-level support, and maintains a commitment to carbon-neutral operations and FSC-certified communications. Selakovic speaks frequently on scaling biologicals, translating lab breakthroughs to farm outcomes, and building resilient, zero-residue value chains.

I am a Risk Management and Cyber Security professional, providing services to public and private sector clients for over 15 years.I graduated from Mount Saint Mary's in 2006 with a Bachelor's Degree in Computer Science.My most worked for award is my rank of Eagle Scout in the Boy Scouts of America, which I received on January 13, 1999.

Apryl Boyle is one of the world's most compelling voices at the intersection of ocean science, surfing, and strategic data. A lifelong surfer, she established herself as a globally recognized ocean authority and scientific storyteller through her pioneering research into marine life, which has been featured across major platforms including National Geographic and Discovery’s Shark Week. She is the author of How to Surf Like a California Girl, and the expert media outlets call on for a data-driven perspective on ocean conservation, coastal ecosystems, and the mental game of surfing. Uniquely, Apryl couples this deep scientific knowledge with an Executive AI Strategy background. As an MIT-certified leader, she specializes in translating complex data—from Media Mix Models to predictive analytics—into clear commercial insights. She is the definitive authority who can bridge the gap between rigorous scientific method and executive business strategy.

Brian is the Chief AI Officer at Health-Vision.AI, LLC, where he leads responsible AI implementation and develops ethical AI, security, and governance frameworks for healthcare and life sciences organizations in the US and EU. He is also the founder of Envision-Health.AI and creator of HealthRoundsAI, a platform that helps future clinicians use AI ethically and communicate more effectively with patients. With decades of public- and private-sector experience in health tech, AI strategy, data governance, and digital innovation, Brian is a recognized thought leader on AI ethics, AI governance, and the societal impacts of AI in healthcare. He also serves as an adjunct instructor in social sciences and AI ethics and has published in JMIR, Public Health Reports, and the Journal of Community Health.

Previously, served as Sales Finance Analyst at Google and VP Data Science, Financial Crime and Fraud at Monzo (UK’s Venmo Bank), joining as one of the early employees and scaling a 120+ person team. With a background in financial engineering and AI, he specializes in risk-compliant automation for regulated industries.

Clinical trial management of two stem cell clinical trials. I have a passion for data science analytics and rigorous pattern-seeking. I believe in leading from the front and making sure the team is well taken care of. *Managing 2 stem cell clinical trials, NCT02838316 and NCT05421689*30 peer-reviewed publications.*>12,000 citations.*2 provisional patents.*Co-founded startup.*Co-developed departmental leadership program.*Strong track record of grant funding and collaboration building.* Associated Editor for two flagship scientific journals (Stem Cells, Journal of Extracellular Biology).GOOGLE SCHOLAR PROFILEhttps://scholar.google.com/citations?user=3uQtjEEAAAAJ&hl=en

I am the Founder of Dholera Smart City Solutions and a specialist Dholera SIR Real Estate Consultant, helping investors, homebuyers, and businesses secure high-value residential, commercial, and industrial properties in India’s fastest-growing smart city — Dholera SIR. With in-depth knowledge of Dholera’s development plans, government approvals, infrastructure updates, and investment hotspots, I provide transparent, data-driven guidance to ensure safe, profitable, and future-ready real estate decisions. I assist clients with: • Residential plots in TP1, TP2, and the Activation Zone • Commercial land near the Expressway, Metro, Airport, and major transport corridors • Industrial land with government approvals • Legal support, plot verification, and accurate pricing insights Why Dholera SIR? As a key node of the Delhi–Mumbai Industrial Corridor (DMIC), Dholera offers world-class infrastructure, mega projects like the International Airport, Metro, and Expressway, and clearly defined investment zones that attract global interest and deliver strong long-term appreciation. Why work with me? • Strong network within the Dholera real estate ecosystem • Transparent guidance backed by verified data • Proven track record of securing high-return plots for clients If you’re exploring investment opportunities in Dholera — residential, commercial, or industrial — I can help you identify the right property at the right price with maximum growth potential.

With experience as an Executive Research Leader, I have a multifaceted background in…